Neuropathic pain: A pathway for care developed by the British Pain Society

British Journal of Anaesthesia

Volumn 111, Issue 1, 2013, Pages 73-79

  Smith, B H ^a   Lee, J ^b   Price, C ^c   Baranowski, A P ^b,d  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

nerve pain; neuralgia; neuropathic pain

Indexed keywords

CAPSAICIN; CARBAMAZEPINE; GABAPENTIN; LIDOCAINE; MORPHINE; OPIATE; PREGABALIN;

ANALGESIA; COMPLEX REGIONAL PAIN SYNDROME; DIABETIC NEUROPATHY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HUMAN; MEDICAL SOCIETY; NEUROPATHIC PAIN; PRIORITY JOURNAL; REVIEW; SECONDARY HEALTH CARE; SYSTEMATIC REVIEW (TOPIC); TERTIARY HEALTH CARE;

EID: 84880206472     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet206     Document Type: Article

References (39)

1. The Mapof Medicine and the British Pain Society. Initial Assessment and Early Management of Pain. London: Map of Medicine, 2012
2. The Map of Medicine and the British Pain Society. Chronic Widespread Pain, Including Fibromyalgia. England View. London: Map of Medicine, 2013
3. The Map of Medicine and the British Pain Society. LowBack Pain and Radicular Pain. England View. London: Map of Medicine, 2013
4. The Map of Medicine and the British Pain Society. Pelvic Pain. England View. London: Map of Medicine, 2013
5. The Map of Medicine and the British Pain Society. Neuropathic Pain. England View. London: Map of Medicine, 2013
6. ElliottAM,SmithBH,PennyKI,ChambersWA,SmithWC.Theepidemiology of chronic pain in the community. Lancet 1999; 354: 1248-52
7. Smith BH, Elliott AM, Chambers WA, Smith WC, Hannaford PC, Penny K. The impact of chronic pain in the community. Fam Pract 2001; 18: 292-9
8. Bridges S. Chronic Pain. In: Craig R, Mindell J, eds. Health Survey for England 2011. Leeds: Health and Social Care Information Centre, 2012. https://catalogue.ic.nhs.uk/publications/public-health/surveys/ heal-surv-eng-2011/HSE2011-Ch9-Chronic-Pain.pdf
9. Jensen TS, BaronR,HaanpaaM, et al.Anewdefinition of neuropathic pain. Pain 2011; 152: 2204-5
10. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull 1991; 47: 644-66
11. Torrance N, Smith BH, Bennett MI, Lee A. The epidemiology of chronic pain of predominantly neuropathic origin: Results from a general population survey. J Pain 2006; 7: 281-9
12. Smith BH, Torrance N, Bennett MI, Lee AJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain 2007; 23: 143-9
13. Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain 2010; 149: 338-44
14. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diab Care 2004; 27: 1047-53
15. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150: 573-81
16. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113-88
17. Haanpää M, Backonja M-M, Bennett M, et al. Assessment of neuropathic pain in primary care. Am J Med 2009; 122: S13-31
18. Haanpää M, Attal N, Backonja M, et al. International Association for the Study of Pain NeuPSIG guidelines on neuropathic pain assessment. Pain 2011; 152: 14-27
19. Dworkin RH, Panarites CJ, Armstrong EP, et al. Is treatment of postherpetic neuralgia in the community consistent with evidencebased recommendations? Pain 2012; 153: 869-75.
20. Torrance N, Ferguson J, Afolabi E, et al. Neuropathic pain in thecommunity: more under-treated than refractory? Pain 2013 (Epub ahead of print). http://dx.doi.org/10.1016/j.pain.2012.12.022
21. Hall GC, Carrol D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006; 122: 156-62
22. National Institute for Health and Clinical Excellence (NICE). Neuropathic Pain-Pharmacological Management. Clinical Guideline 96. London: NICE, 2010.
23. British Pain Society (BPS). Opioids for Persistent Pain: Good Practice. London: BPS, 2010
24. British Pain Society (BPS). Neuropathic Pain.Working Group Consensus Opinion. London: BPS, 2012
25. National Institute for Health and Clinical Excellence (NICE). Spinal Cord Stimulation for Chronic Pain of Neuropathic or Ischaemic Origin. Technology appraisal 159. London: NICE, 2008
26. National Institute for Health and Clinical Excellence (NICE). Deep Brain Stimulation for Refractory Chronic Pain Syndromes (excluding headache). Interventional procedure guidance 382. London: NICE, 2011
27. Irving G, Backonja M, Rauck R, et al. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia. Clin J Pain 2012; 28: 101-7
28. BMA, Royal Pharmaceutical Society. British National Formulary. 64 (September 2012). London: BMJ Group and Pharmaceutical Press, 2012
29. Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain 2007; 127: 199-203
30. Goebel A, Barker C, Turner-Stokes L, Guideline Development Panel. Complex Regional Pain Syndrome in Adults: UK Guidelines for Diagnosis, Referral and Management in Primary and Secondary care. London: Royal College of Physicians, 2012. http://www.rcplondon .ac.uk/resources/complex-regional-pain-syndrome- guidelines
31. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118: 289-305
32. Smith BH, Higgins C, Baldacchino A, et al. Gabapentin as a drug of abuse. Br J Gen Pract 2012; 62: 406-7
33. Cruccu G, Gronsethb G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008; 15: 1013-28
34. Shaikh S, Yaacob HB,RahmanRBA. Lamotrigine for trigeminal neuralgia: efficacyandsafety in comparison with carbamazepine. J Chin Med Assoc 2011; 74: 243-9
35. Edlund MJ, Martin BC, Fan MY, et al. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend 2010; 112: 90-8
36. Stannard CF. Opioids for chronic pain: promiseandpitfalls. Curr Opin Support Palliat Care 2011; 5: 150-7
37. Turner JA, Hollingworth W, Comstock B, Deyo RA. Comparative effectiveness research and policy: experiences conducting a coverage with evidence development study of a therapeutic device. Med Care 2010; 48: S129-36
38. Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev 2012; 7: CD008943
39. Turk DC, Audette J, LevyRM, et al.Assessmentandtreatmentof psychosocial comorbidities in patients with neuropathic pain. Mayo Clin Proc 2010; 85(3 Suppl.): S42-50